"Chemokine CXCL9" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An INTEFERON-inducible CXC chemokine that is specific for the CXCR3 RECEPTOR.
| Descriptor ID |
D054370
|
| MeSH Number(s) |
D12.644.276.374.200.120.450 D12.776.467.374.200.120.450 D23.125.300.120.450 D23.469.200.120.450 D23.529.374.200.120.450
|
| Concept/Terms |
Chemokine CXCL9- Chemokine CXCL9
- CXCL9, Chemokine
- CXCL9 Chemokine
- Chemokine, CXCL9
- Monokine Induced by gamma Interferon Chemokine
- SCYB9 Chemokine
- Chemokine, SCYB9
- Small Inducible Cytokine B9
- Chemokine (C-X-C Motif) Ligand 9 Protein
- Mig Chemokine
- Chemokine, Mig
|
Below are MeSH descriptors whose meaning is more general than "Chemokine CXCL9".
Below are MeSH descriptors whose meaning is more specific than "Chemokine CXCL9".
This graph shows the total number of publications written about "Chemokine CXCL9" by people in this website by year, and whether "Chemokine CXCL9" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 1 | 2 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemokine CXCL9" by people in Profiles.
-
Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCT. Blood Adv. 2023 07 25; 7(14):3725-3734.
-
Suppression of Th1-Mediated Keratoconjunctivitis Sicca by Lifitegrast. J Ocul Pharmacol Ther. 2018 09; 34(7):543-549.
-
Desiccating stress-induced chemokine expression in the epithelium is dependent on upregulation of NKG2D/RAE-1 and release of IFN-? in experimental dry eye. J Immunol. 2014 Nov 15; 193(10):5264-72.
-
Beyond the IFN-? horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis. Eur Respir J. 2014 May; 43(5):1472-86.
-
Lipocalin 2 regulates inflammation during pulmonary mycobacterial infections. PLoS One. 2012; 7(11):e50052.
-
Epigallocatechin-3-gallate reduces airway inflammation in mice through binding to proinflammatory chemokines and inhibiting inflammatory cell recruitment. J Immunol. 2011 Mar 15; 186(6):3693-700.
-
Expression of CXCL9, -10, -11, and CXCR3 in the tear film and ocular surface of patients with dry eye syndrome. Invest Ophthalmol Vis Sci. 2010 Feb; 51(2):643-50.
-
Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease. Arthritis Rheum. 2009 Jul; 60(7):2183-92.
-
Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy. Clin Cancer Res. 2009 Jul 15; 15(14):4589-99.
-
Virologic and immunologic events in hilar lymph nodes during simian immunodeficiency virus infection: development of polarized inflammation. J Acquir Immune Defic Syndr. 2008 Jan 01; 47(1):16-26.